Valuation: Harbin Gloria Pharmaceuticals Co., Ltd

Market Cap 9.59B 1.43B 1.22B 1.14B 1.04B 1.97B 136B 1.99B 13.48B 5.25B 68.63B 5.36B 5.25B 227B P/E 2024
24.2x
P/E 2025 18.2x
Enterprise Value 8.75B 1.3B 1.11B 1.04B 953M 1.8B 124B 1.82B 12.3B 4.79B 62.63B 4.9B 4.79B 208B EV / Sales 2024
2.12x
EV / Sales 2025 2.82x
Free-Float
90.63%
Yield 2024 *
-
Yield 2025 -
1 day+9.14%
1 week-13.65%
Current month+50.88%
1 month+55.80%
3 months+38.26%
6 months+27.22%
Current year+40.07%
1 week 3.86
Extreme 3.86
5.03
1 month 2.72
Extreme 2.72
5.1
Current year 2.37
Extreme 2.37
5.1
1 year 2.37
Extreme 2.37
5.1
3 years 1.66
Extreme 1.66
5.1
5 years 1.66
Extreme 1.66
5.1
10 years 1.66
Extreme 1.66
9.8
Manager TitleAgeSince
Chief Executive Officer 53 26/12/2022
Corporate Officer/Principal 42 18/04/2018
Corporate Officer/Principal 40 23/05/2019
Director TitleAgeSince
Director/Board Member 40 14/03/2025
Director/Board Member 53 11/11/2022
Director/Board Member 42 11/11/2022
Date Insider Type Main position Quantity % Market Cap.
02/07/25 Sell 587,500 0.0283%
02/07/25 Sell

Director

259,600 0.0125%
02/07/25 Sell 587,500 0.0283%
Change 5-day change 1-year change 3-year change Capi.($)
+9.14%-13.65%+19.11%+103.79% 1.31B
+0.63%+2.13%+17.07%+71.87% 47.86B
-0.98%+0.62%+49.89%+120.98% 40.33B
-1.11%-0.66%-10.72%+16.51% 12.13B
+1.88%-0.62%+13.72%+75.47% 11.5B
+0.19%0.00%+30.98%+154.90% 9.1B
+0.23%+2.77%+24.98%+46.41% 7.82B
+0.61%+2.10%+48.04%-11.10% 7.22B
+0.39%+3.05%+23.88%+220.36% 7.05B
+0.95%-9.11%-39.48%+14.70% 5.24B
Average +1.19%+0.27%+17.75%+81.39% 14.96B
Weighted average by Cap. +0.18%+0.91%+24.52%+85.88%

Financials

2024 2025
Net sales 2.44B 364M 311M 291M 266M 502M 34.7B 508M 3.43B 1.34B 17.47B 1.37B 1.34B 57.9B 2.14B 318M 272M 254M 233M 439M 30.36B 444M 3B 1.17B 15.28B 1.19B 1.17B 50.66B
Net income 233M 34.69M 29.65M 27.74M 25.36M 47.89M 3.31B 48.41M 327M 127M 1.67B 130M 127M 5.52B 377M 56.17M 48.01M 44.92M 41.07M 77.55M 5.36B 78.4M 530M 206M 2.7B 211M 206M 8.94B
Net Debt -509M -75.81M -64.79M -60.62M -55.42M -105M -7.23B -106M -715M -279M -3.64B -285M -278M -12.07B -838M -125M -107M -99.87M -91.31M -172M -11.91B -174M -1.18B -459M -6B -469M -459M -19.88B
Logo Harbin Gloria Pharmaceuticals Co., Ltd
HARBIN GLORIA PHARMACEUTICALS Co Ltd is a China-based company principally engaged in the research, development, production and sale of pharmaceuticals. The Company operates its businesses through three segments. The Traditional Chinese Medicine segment's main product is Annao Pills and Tablets. The Chemical Pharmaceuticals segment's products include cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamins, electrolytes, analgesics, anti-infectives, anti-tumor drugs and others. The Others segment engages in pharmaceutical research and development, clinical services and others. The Company distributes its products within the domestic market and to overseas markets.
Employees
2,350
Date Price Change Volume
25/08/26 CN¥4.300 +9.14% 790,417,714
24/08/26 CN¥3.940 -9.43% 566,879,321
21/08/26 CN¥4.350 -8.03% 668,639,264
20/08/26 CN¥4.730 +10.00% 482,130,266
19/08/26 CN¥4.300 -9.66% 738,255,582

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002437 Stock